BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30756420)

  • 1. MSK2 promotes proliferation and tumor formation in squamous cervical cancer via PAX8/RB-E2F1/cyclin A2 axis.
    Wu Y; Li H; Wang H; Zhang F; Cao H; Xu S
    J Cell Biochem; 2019 Jul; 120(7):11432-11440. PubMed ID: 30756420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein.
    Li CG; Nyman JE; Braithwaite AW; Eccles MR
    Oncogene; 2011 Dec; 30(48):4824-34. PubMed ID: 21602887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.
    Chang MM; Lai MS; Hong SY; Pan BS; Huang H; Yang SH; Wu CC; Sun HS; Chuang JI; Wang CY; Huang BM
    Cancer Sci; 2018 Nov; 109(11):3503-3518. PubMed ID: 30191630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the STAT5-cyclin D/CDK4-pRb pathway in β-cell proliferation stimulated by prolactin during pregnancy.
    Zhao X; Xu Y; Wu Y; Zhang H; Shi H; Zhu H; Woo M; Wu X
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E135-E144. PubMed ID: 30512986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
    Xiong Y; Li T; Assani G; Ling H; Zhou Q; Zeng Y; Zhou F; Zhou Y
    Biomed Pharmacother; 2019 Apr; 112():108602. PubMed ID: 30784916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphene suppresses oesophageal cancer growth through mitogen- and stress-activated kinase 2 in a PDX mouse model.
    Zhang C; Wu Q; Yao K; Jin G; Zhao S; Zhang J; Zheng W; Xu B; Zu Y; Yuan J; Liu K; Guo Y
    Am J Cancer Res; 2023; 13(10):4708-4720. PubMed ID: 37970356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex.
    Madan E; Gogna R; Kuppusamy P; Bhatt M; Pati U; Mahdi AA
    Br J Cancer; 2012 Jul; 107(3):516-26. PubMed ID: 22782351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of mitogen- and stress-activated protein kinase-1 and -2 (MSK1 and MSK2) by CK2 following UV radiation.
    Jacks KA; Koch CA
    J Biol Chem; 2010 Jan; 285(3):1661-70. PubMed ID: 19933278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
    Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
    Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.
    Chen M; Zhao Z; Wu L; Huang J; Yu P; Qian J; Ni T; Zhao C
    Cell Death Dis; 2022 Sep; 13(9):784. PubMed ID: 36096885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinoblastoma protein selectively represses E2F1 targets via a TAAC DNA element during cellular senescence.
    Chen T; Xue L; Niu J; Ma L; Li N; Cao X; Li Q; Wang M; Zhao W; Li G; Wang J; Tong T
    J Biol Chem; 2012 Oct; 287(44):37540-51. PubMed ID: 22955272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic significance of PAX8 in thyroid squamous cell carcinoma.
    Suzuki A; Hirokawa M; Takada N; Higuchi M; Yamao N; Kuma S; Daa T; Miyauchi A
    Endocr J; 2015; 62(11):991-5. PubMed ID: 26354716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer.
    Jin G; Yan M; Liu K; Yao K; Chen H; Zhang C; Yi Y; Reddy K; Gorja DR; Laster KV; Guo Z; Dong Z
    Oncogene; 2020 Oct; 39(43):6733-6746. PubMed ID: 32963350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
    Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex.
    Zhou M; Yang Z; Wang D; Chen P; Zhang Y
    J Exp Clin Cancer Res; 2021 Jan; 40(1):48. PubMed ID: 33516252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the p16/cyclin D1/CDK4/Rb/E2F1 pathway on aberrant lung fibroblast proliferation in neonatal rats exposed to hyperoxia.
    Zhao S; Chen Z; Han S; Wu H
    Exp Ther Med; 2021 Oct; 22(4):1057. PubMed ID: 34434271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC.
    Wang SN; Wang LT; Sun DP; Chai CY; Hsi E; Kuo HT; Yokoyama KK; Hsu SH
    Oncotarget; 2016 Jun; 7(24):36924-36939. PubMed ID: 27175585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.